GW28-e1182 The safe and effective analysis of patients who accepted percutaneous coronary intervention with digestive system diseases, given cilostazol and Ticagrelor

Percutaneous coronary intervention (PCI) is an important method in the treatment of acute coronary syndrome (ACS). Dual antiplatelet drug therapy has been used as the main means to inhibit the thrombosis of the lesion site after PCI, and aspirin with clopidogrel is the most common. But there are